PHAT EBITDA Margin
Phathom Pharmaceuticals Inc · EBITDA Margin
PHAT EBITDA Margin
Latest reported-14.66%period ending
PHAT TTM EBITDA Margin (-23320.97% → -14.66%)
TTM ebitda margin
High-resolution chart · PNG
PHAT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -14.661% | |
| -44.3609% | |
| -87.087% | |
| -138.2988% | |
| -225.1486% | |
| -332.4253% | |
| -473.3259% | |
| -1,036.2124% | |
| -2,402.9643% | |
| -7,558.5197% | |
| -23,320.9677% |